BlueLinx (BXC) Q2 2024 earnings summary

Executive summary

• Q2 2024 net sales were $768 million, down 5.8%-6% year-over-year, with specialty products comprising about 70% of sales and 85% of gross profit.

• Net income was $14 million ($1.65 per share), adjusted net income $15 million ($1.68 per share), with adjusted EBITDA of $34 million (4.5% margin), including a $2.7 million duty-related benefit.

• Gross margin was 15.9%, with specialty products at 19.3% and structural products at 7.9%.

• Specialty product revenues declined 5.5%-6% year-over-year due to price deflation, but volumes grew slightly; structural product revenues fell 6.6%-7% with margin compression.

• Strong liquidity and balance sheet, with $491 million in cash and net leverage of (0.9x), support ongoing growth, digital transformation, and capital returns.

Financial highlights

• Net sales decreased 5.8%-6% year-over-year to $768 million; gross profit was $122 million (15.9% margin), down 70 bps.

• Adjusted net income was $15 million ($1.68 per share); net income was $14 million ($1.65 per share).

• Adjusted EBITDA was $34 million (4.5% of net sales), including a $2.7 million import duty-related benefit.

• Operating cash flow was $36 million; free cash flow was $29 million.

• SG&A expenses were $89-$98.6 million, up slightly year-over-year due to technology and legal costs.

Outlook and guidance

• Management expects continued headwinds from housing market softness and elevated mortgage rates, with negative pricing comps likely through Q4 2024.

• Specialty product gross margins expected to remain in the 18%-19% range; structural margins at 8%-9%.

• Industry recovery now expected to begin in 2025, contingent on sustained interest rate cuts.

• Liquidity sources are expected to be sufficient for at least the next 12 months.